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Background:Theart of recombinantproteinproduction inE.coli
andmammalian system needs an extensive infrastructure to adopt
GMP practice for large-scale production and this makes the ﬁnal
product very expensive and such therapeutics may not be afford-
able where it is needed the most. The potential of plant biologics
over the conventional systems is, it has glycosylation pattern or
with a choice of non-glycosylation containment i.e. in chloroplast,
established genetic and glycoengineering methods, adaptability,
scalability and affordability. Plant molecular farming in simple
words ‘the use of plants for the production of protein therapeutics’
became popular due to the Magnifection technology, degenerative
vectors and glycoengineered plants. Our studies involved the usage
of current technology for expression and puriﬁcation of Chikun-
gunya vaccine candidates and mAb’s in plant system and also
manifests the compatibility of plant host system for the expression
of S.aureus superantigenic proteins with the proven immunogenic
functions.
Methods & Materials: The CHIKV vaccine candidates E1 and E2,
bacterial superantigenic peptides TSST-1 and fusion gene rTE and
anti-CHIKV mAb’s (8B10 and 5F10 were retrieved from European
patent application EP2374 816 A1) were cloned into the current
generation high expression plant constructs like pEAQ-HT-DEST
and pTRAK through gateway cloning technology and conventional
cloning. Constructsweremobilized intoAgrobacterium andvacuum
inﬁltrated in N.benthamiana plants following standard procedures.
Following 5th day of post inﬁltration leaves were harvested and
recombinantproteinwaspuriﬁedbyhis-tagandproteinA/Gafﬁnity
based puriﬁcation techniques respectively.
Results: We have successfully produced CHIKV vaccine can-
didates E1 and E2 (8-13mg/kg of fresh leaf weight), antibodies
(20-30mg/kg) and the bacterial recombinant superantigen TSST-
1 and hypothetical vaccine candidate rTE fusion proteins (5.4 and
6.7mg/kg). The in vivo and in vitro immunogenicity and neutral-
ization studies revealed that the plant produced antigens and
antibodies elicit good immune responses.
Conclusion: The level of expression, glycosylation and immu-
nizing potential are the evidence strongly suggesting the plants are
the potential alternate system. So, we propose plant biologics as a
promising system during an epidemic like situation as scale-up of
this system is inﬁnity at an affordable cost, which will help the
people, where it is needed the most.
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